SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sharon Bio-Medicine touches roof on receiving consent to operate API plant at Raigad

11 May 2018 Evaluate

Sharon Bio-Medicine is locked at upper circuit at Rs. 5.10, up by 0.24 points or 4.94% from its previous closing of Rs. 4.86 on the BSE.

The scrip opened at Rs. 5.10 and has touched a high and low of Rs. 5.10 and Rs. 5.10 respectively. So far 6,100 shares were traded on the counter.

The BSE group 'Z' stock of face value Rs. 2 has touched a 52 week high of Rs. 10.10 on 11-Jan-2018 and a 52 week low of Rs. 4.68 on 09-May-2018.

Last one week high and low of the scrip stood at Rs. 5.30 and Rs. 4.68 respectively. The current market cap of the company is Rs. 53.84 crore.

The promoters holding in the company stood at 32.53%, while Non-Institutions held 67.47% stake in the company.

Sharon Bio-Medicine has received consent to operate its API plant located at L-6, MIDC, Taloja, Raigad district in state of Maharashtra from Maharashtra Pollution Control Board under Water Act, 197 4 and Air Act, 1981.

Earlier in March, the company had temporarily suspended operations at its API plant on the directions of Central Pollution Control Board in accordance with the provisions of Environment (Protection) Act, 1986.

Sharon Bio-Medicine is a specialty pharmaceutical company. The company is engaged in the development, manufacture and commercialization of pharmaceutical products.


Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×